0000000001074909

AUTHOR

Paolo Lanzetta

showing 2 related works from this author

Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema.

1997

Abstract Purpose: To compare the efficacy and tolerance of diclofenac 0.1 % eyedrops with a regimen that included a brief course of steroids in the treatment of postoperative inflammation after extracapsular cataract surgery and posterior chamber intraocular lens implantation. A second objective was to compare the efficacy of diclofenac 0.1% eyedrops in the same patients and control group in preventing cystoid macular edema (CME). Setting: Eight university/hospital centers and one company in Italy. Methods: The multicenter, controlled, randomized, prospective, double-blind study included 281 patients. All were evaluated at baseline, at surgery, and after 1, 5, 36, 67, and 140 days. Postoper…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentInflammationDiclofenac SodiumCataract surgerymedicine.diseaseFluorescein angiographySensory SystemsSurgeryOphthalmologyRegimenDiclofenacAnesthesiaRelative riskMedicineSurgerymedicine.symptombusinessMacular edemamedicine.drug
researchProduct

Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and me…

2017

PubMed: 28779882

AFRICAPopulation ageingmedicine.medical_specialtyVisual acuity[SDV]Life Sciences [q-bio]PopulationVisual impairmentVision DisordersVisual AcuityEYEBlindnessGlobal Health03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-being[SDV.IDA]Life Sciences [q-bio]/Food engineeringPrevalenceJournal ArticleGlobal healthHumansMedicineVISUAL IMPAIRMENT[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process Engineering030212 general & internal medicineeducationPublic Environmental & Occupational Healtheducation.field_of_studyScience & Technologybusiness.industryMORTALITYPublic healthlcsh:Public aspects of medicineMedicine (all)COSTlcsh:RA1-1270General MedicinePresbyopiamedicine.diseaseVision Loss Expert Group3. Good healthMeta-analysis030221 ophthalmology & optometry/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingHEALTHmedicine.symptombusinessLife Sciences & BiomedicineDemography
researchProduct